Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%), etc.
Feb 14 17:02 ET
Kiora Pharmaceuticals | D: Filing D
Feb 14 15:54 ET
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Feb 13 20:12 ET
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
Feb 9 16:21 ET
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.9%),Orin H(9.9%)
Feb 7 09:26 ET
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.5%),Daniel B. Asher(1.5%), etc.
Feb 6 10:32 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tosca Melissa
Oct 3, 2023 16:49 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Daniels Eric Joseph
Oct 3, 2023 16:48 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Strem Brian M.
Oct 3, 2023 16:47 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director TYLE PRAVEEN
Oct 3, 2023 16:46 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shapiro Aron
Oct 3, 2023 16:46 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stengone Carmine N.
Oct 3, 2023 16:45 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hollander David
Oct 3, 2023 16:44 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gayron Kenneth L
Oct 3, 2023 16:44 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Parsons Erin
Oct 3, 2023 16:43 ET
Kiora Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Stengone Carmine N.
Aug 10, 2023 17:23 ET
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Jun 13, 2023 16:02 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Parsons Erin
Mar 7, 2023 20:15 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tosca Melissa
Mar 7, 2023 20:15 ET
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Strem Brian M.
Mar 7, 2023 20:15 ET
No Data
No Data